["{\"step_by_step_thinking\": \"The documents provided do not mention capmatinib as a treatment option for glioblastoma. The papers discuss the current treatment perspectives which include cytoreduction through multimodality therapy, clinical trials such as those offered by the Brain Tumor Cooperative Group, and available therapies in medical, surgical, radiation, and chemotherapeutic realms. There is no mention of capmatinib as a treatment option for glioblastoma. Therefore, based on the provided information, we can conclude that there is no evidence to suggest that capmatinib is effective for glioblastoma.\", \"answer_choice\": \"B\"}"]